XClinical, a European vendor of innovative software products for eClinical trials, known for its innovative and user-friendly CDISC ODM certified EDC software suite MARVIN, today announced its comprehensive participation at the CDISC Interchange in Tokyo, Japan.

XClinical will exhibit together with its Japanese CRO partner ASKLEP at the CDISC event. ASKLEP has two projects running in Japan using MARVIN in the Japenese language. XClinical and ASKLEP welcome visitors to drop by their booth during the event to view demonstrations of MARVIN.

In addition to attending as exhibitor, XClinical’s Head of Business Development, Dr. Claus Lindenau, will be speaking in the session “CDISC End-To-End”. In his presentation he will talk about the benefits of using CDISC ODM certified tools to define the CRF structure and the metadata of a CRF. This includes for example the advantages for generating database table definitions and annotated CRF as well as the validation of the CRF structure.

About XClinical

XClinical GmbH (www.xclinical.com), an innovative EDC-CDM system vendor based in Munich, Paris and Boston, USA, provides solutions for the electronic conduct of all types of clinical trials, post-marketing studies and registries.
XClinical develops and markets MARVIN, a CDISC ODM certified online platform for Electronic Data Capture (EDC), Clinical Data Management (CDM) and Clinical Trial Management (CTM). Till today, MARVIN was used to collect and process data of more than 50,000 patients in 70+ studies.

About Asklep

Asklep, Inc., (www.asklep.co.jp ) founded in 1992, in Tokyo, Japan, provides clinical research services in monitoring, data management, biostatistics, regulatory & consulting, CRA training, etc. ASKLEP is an INTAGE Group Company. INTAGE, INC., (www.intage.co.jp) is the largest marketing research company in Japan and the eleventh largest globally. It has one of the most comprehensive healthcare solution services in the industry.